How to Value a Direct Primary Care (DPC) Practice in 2026

Direct Primary Care is the first primary care business model I've seen in 20 years that actually behaves like a real business instead of a cost center. No insurance billing, no prior auths, no denied claims, no RCM headaches. Patients pay $75-$150 a month, the doctor sees fewer of them, and the margins look more like a SaaS company than a medical practice.

That changes how it gets valued. Traditional primary care trades on EBITDA because buyers are pricing a clinical P&L. DPC trades on revenue multiples because buyers are pricing a recurring subscription book. Here's how it actually works in 2026.

Why DPC Trades on Revenue, Not EBITDA

A DPC practice with 600 members at $99/month generates roughly $712K in annual recurring revenue. The cost structure is simple: one physician, one medical assistant, a small office, a basic EHR, some lab and dispensing costs. EBITDA margins of 35-50% are common, versus 12-20% in traditional primary care.

But buyers don't value DPC on EBITDA for the same reason no one values SaaS on EBITDA: the recurring revenue itself is the asset. A healthy DPC practice with low churn and a waitlist is a predictable cash flow stream that compounds. The market has settled on 3-5x annual recurring revenue as the working range, with most deals landing at 3.5-4.5x ARR.

On that 600-member, $712K ARR practice, you're looking at $2.5M-$3.2M in enterprise value — roughly 2-3x what the same practice would fetch if it were billing insurance on the same patient panel.

The Metrics That Actually Matter

Forget your P&L for a minute. The five numbers that drive DPC valuation are the same numbers that drive any subscription business:

• Active members: the core unit of value. 400 members is a working practice, 600+ is healthy, 800+ requires extender staff or a waitlist model.
• Monthly churn: under 1.5% is excellent, 2-3% is normal, 4%+ is a red flag. Buyers discount hard for churn above 3%.
• Average revenue per member (ARPM): $75-$150/month depending on market. Employer-contract members often skew higher.
• Member tenure: the percentage of members who've been enrolled 24+ months. High tenure proves sticky economics.
• Waitlist depth: an active waitlist of 40+ prospects signals pricing power and removes growth risk for the buyer.

A practice with 600 members, 1% monthly churn, $115 ARPM, and a 60-patient waitlist is worth meaningfully more than a practice with 700 members, 4% churn, $85 ARPM, and no waitlist — even though the bigger practice has higher top-line revenue.

Employer Contracts Are the Real Upside

Individual members are the core of DPC, but employer contracts are where the valuation multiple stretches. When a local business signs up to cover DPC membership for its employees as a benefit, you get:

A block of 20-200 members added in a single contract. Lower acquisition cost per member. Lower churn (employees stay enrolled as long as the contract renews). Often higher ARPM because employers negotiate bundled services. And most importantly, a real growth channel that doesn't depend on word-of-mouth or Facebook ads.

Practices with 30-50% of members coming through employer contracts trade at the top of the 3-5x ARR range, because buyers see a B2B sales motion they can scale. Nextera Healthcare, Paladina Health (now Everside Health / Marathon Health), and Crossover Health built entire businesses on this model, and their acquisition activity sets market expectations for smaller independent DPCs.

Who's Buying DPC Practices in 2026

The buyer pool is small but real, and it's growing:

• Regional DPC platforms: operators like Nextera, Strada Healthcare, and regional independents building multi-site networks. Most active buyers at the $500K-$5M transaction range.
• Employer health platforms: Marathon Health, Everside, Crossover, Proactive MD, Premise Health. They're less likely to buy a single-site DPC but will acquire to enter a new metro.
• Another DPC physician: common for sub-$1M transactions. Typically structured with a long transition period and seller financing.
• Private equity (emerging): a handful of PE funds have started looking at DPC as a platform thesis. Not a dominant buyer yet, but expect more activity through 2026-2027.

Notably absent: traditional health systems and insurance-based PE platforms. They understand the model intellectually but can't integrate it culturally — DPC physicians who sold to large systems have a bad track record of leaving within 24 months and taking their panels with them.

What Destroys DPC Value

High churn. Churn is the silent killer in DPC valuation. A practice losing 4% of members monthly is replacing its entire book every two years, which means the "recurring" revenue isn't actually recurring. Buyers apply a discount rate based on churn, and the delta between 1% and 4% monthly churn can cut your multiple in half.

Founder-dependent brand. If members chose your practice because of you specifically — your podcast, your local reputation, your personality — the buyer is paying for a brand that walks out the door. Building a practice brand that's bigger than the physician (even a simple one: "Valley Direct Care" rather than "Dr. Smith's DPC") is worth real money at exit.

No extender staff. A solo DPC capped at 600 members has no growth path without cloning the physician. Practices with an NP or PA that can absorb another 300-400 members immediately justify a higher multiple because the buyer sees growth runway.

Weak dispensing and lab economics. Good DPCs run in-house dispensing and wholesale labs, which adds 10-15% to effective ARPM at almost zero marginal cost. If you're not doing this, you're leaving margin on the table and buyers will notice.

How to Maximize Your DPC Exit

Fix churn first. Before anything else, get your monthly churn below 2%. Exit interviews, onboarding improvements, payment plan options, family discounts — whatever it takes. A 12-month trend of improving churn is the single most powerful thing you can show a buyer.

Land employer contracts. Even two or three small employer accounts (25-50 members each) fundamentally change your valuation story from "solo practice" to "B2B2C platform." Focus on local employers with 30-150 employees who are priced out of traditional group health.

Build recurring data. Buyers want 24+ months of clean member count, churn, ARPM, and cohort retention data. If you've been tracking this in a spreadsheet, clean it up. If you haven't, start now — you can't recreate historical retention curves.

Normalize your owner compensation. Just like any other practice sale, buyers want to see SDE or EBITDA with owner comp adjusted to market rate ($220-$260K for a DPC physician). This matters less than ARR in the final valuation but it's a sanity check buyers run to make sure the business can actually pay a salaried replacement doctor.

The Bottom Line

DPC is the rare corner of primary care where the economics actually favor the physician. At 3.5-4.5x ARR, a well-run 600-member practice generates exit value in the $2.5M-$3.2M range — numbers a traditional family physician can only dream about. But the buyer pool is narrower, the metrics buyers care about are different, and the things that kill value (churn, founder dependency) are harder to fix in the final stretch. If you're running a DPC and thinking about a 3-5 year exit, start treating it like a subscription business today.